Cargando…

The Role of Clusterin Transporter in the Pathogenesis of Alzheimer’s Disease at the Blood–Brain Barrier Interface: A Systematic Review

Alzheimer’s disease (AD) is considered a chronic and debilitating neurological illness that is increasingly impacting older-age populations. Some proteins, including clusterin (CLU or apolipoprotein J) transporter, can be linked to AD, causing oxidative stress. Therefore, its activity can affect var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fareed, Muhammad Mazhar, Qasmi, Maryam, Aziz, Shaan, Völker, Elisabeth, Förster, Carola Yvette, Shityakov, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599067/ https://www.ncbi.nlm.nih.gov/pubmed/36291661 http://dx.doi.org/10.3390/biom12101452

Ejemplares similares

In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter
por: Shityakov, Sergey, et al.
Publicado: (2014)

Glucocorticoids and endothelial cell barrier function
por: Salvador, Ellaine, et al.
Publicado: (2013)

Blood–brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate
por: Shityakov, Sergey, et al.
Publicado: (2015)

Role of Milk-Derived Antibacterial Peptides in Modern Food Biotechnology: Their Synthesis, Applications and Future Perspectives
por: Khan, Muhammad Usman, et al.
Publicado: (2018)

Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer’s Disease—Are Systemic Approaches for Diagnosis and Therapy Required?
por: Förster, Carola Y., et al.
Publicado: (2022)

In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
por: Shityakov, Sergey, et al.
Publicado: (2014)

Pharmacokinetic Delivery and Metabolizing Rate of Nicardipine Incorporated in Hydrophilic and Hydrophobic Cyclodextrins Using Two-Compartment Mathematical Model
por: Shityakov, Sergey, et al.
Publicado: (2013)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
por: Shityakov, Sergey, et al.
Publicado: (2021)

Sevoflurane-Sulfobutylether-β-Cyclodextrin Complex: Preparation, Characterization, Cellular Toxicity, Molecular Modeling and Blood-Brain Barrier Transport Studies
por: Shityakov, Sergey, et al.
Publicado: (2015)

α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
por: Shityakov, Sergey, et al.
Publicado: (2012)

Gene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia
por: Shityakov, Sergey, et al.
Publicado: (2015)

The Conspicuous Link between Ear, Brain and Heart–Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer’s Disease and Associated Amyloid Cardiomyopathy?
por: Shityakov, Sergey, et al.
Publicado: (2021)

No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012)

Clusterin transduces Alzheimer-risk signals to amyloidogenesis
por: Liu, Xi, et al.
Publicado: (2022)

Evaluation and Prediction of the HIV-1 Central Polypurine Tract Influence on Foamy Viral Vectors to Transduce Dividing and Growth-Arrested Cells
por: Shityakov, Sergey, et al.
Publicado: (2014)

Modeling of shotgun sequencing of DNA plasmids using experimental and theoretical approaches
por: Shityakov, Sergey, et al.
Publicado: (2020)

In Silico Modeling of Indigo and Tyrian Purple Single-Electron Nano-Transistors Using Density Functional Theory Approach
por: Shityakov, Sergey, et al.
Publicado: (2017)

Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
por: Ling, I-Fang, et al.
Publicado: (2012)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Blood Biomarkers in Takotsubo Syndrome Point to an Emerging Role for Inflammaging in Endothelial Pathophysiology
por: Nagai, Michiaki, et al.
Publicado: (2023)

Three-dimensional quantitative structure–activity relationship and docking studies in a series of anthocyanin derivatives as cytochrome P450 3A4 inhibitors
por: Shityakov, Sergey, et al.
Publicado: (2014)

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
por: Bauskar, Aditi, et al.
Publicado: (2015)

Alzheimer's risk variants in the clusterin gene are associated with alternative splicing
por: Szymanski, M, et al.
Publicado: (2011)

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016)

The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function
por: Shityakov, Sergey, et al.
Publicado: (2022)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker
por: Islam, Kamrul, et al.
Publicado: (2018)

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019)

Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
por: Bradley, David
Publicado: (2020)

Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
por: Bungon, Theodore, et al.
Publicado: (2021)

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
por: Tang, Lian, et al.
Publicado: (2022)

Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin
por: Shityakov, Sergey, et al.
Publicado: (2014)

Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer’s Disease
por: Chen, Ping, et al.
Publicado: (2013)

Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers
por: Jackson, Rosemary J, et al.
Publicado: (2019)

The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019)

Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)

Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
por: Qi, Xue-Mei, et al.
Publicado: (2018)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang, Jun, et al.
Publicado: (2020)

Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk
por: Ma, Jin, et al.
Publicado: (2022)

The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
por: Hsu, Jung-Lung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uiqekbkhqm47okv16adp4jd8nm